©The Author(s) 2025.
World J Gastrointest Surg. Dec 27, 2025; 17(12): 112256
Published online Dec 27, 2025. doi: 10.4240/wjgs.v17.i12.112256
Published online Dec 27, 2025. doi: 10.4240/wjgs.v17.i12.112256
Table 3 Summary of the basic characteristics of the included studies
| Ref. | Years | Types | Sample size (n) | Ages (year) | Gender (male/female) | Dose of Ala-Gln | Route | Time of duration | |||
| Control | Experimental | Control | Experimental | Control | Experimental | ||||||
| Zhao et al[30] | 2022 | CC | 44 | 44 | 54.31 ± 5.62 | 55.26 ± 5.86 | 25/19 | 23/21 | 20 g/d | PN | Preop. 3 days-postop |
| Zhao et al[31] | 2019 | CRC | 28 | 32 | 54.42 ± 5.21 | 56.75 ± 5.60 | 19/9 | 22/10 | 50 mL | PN | Preop. 24 hours and postop. 1 hour |
| Zhang et al[32] | 2008 | CRC | 47 | 47 | 57.35 ± 16.4 | NR | 100 mL/d | PN | POD1-7 | ||
| Yuan et al[33] | 2011 | CRC | 30 | 30 | 61.83 ± 6.23 | 62.57 ± 7.38 | 15/15 | 15/15 | 0.4 g /kg/d | PN | Preop. 4 days-postop |
| Xu et al[34] | 2006 | CRC | 30 | 30 | NR | NR | NR | PN | POD1-7 | ||
| Wang et al[35] | 2005 | CRC | 20 | 19 | NR | NR | 0.4 g /kg/d | PN | Postop. | ||
| Wang et al[36] | 2008 | RC | 30 | 30 | 60.3 ± 4.5 | 58.7 ± 3.6 | 11/19 | 17/13 | 0.3 g /kg/d | PN | POD1-7 |
| Song et al[37] | 2002 | CRC | 20 | 20 | 56.6 ± 12.1 | 55.4 ± 17.1 | 12/8 | 13/7 | 0.3-0.4 g /kg/d | PN | POD1-7 |
| Li et al[38] | 2002 | CRC | 20 | 20 | 58.02 ± 4.63 | 57.81 ± 3.75 | 10/10 | 11/9 | NR | PN | POD1-7 |
| Huang et al[39] | 2006 | CRC | 15 | 15 | 56.8 ± 3.5 | 57.0 ± 4.7 | 9/6 | 7/8 | 0.4 g /kg/d | PN | POD1-5 |
| Cui et al[40] | 2011 | CC | 20 | 20 | 56 ± 11 | 55 ± 11 | 11/9 | 12/8 | 0.5 g/kg | PN | Preop. 24 hours and postop.1 hour |
| Chen et al[41] | 2019 | CC | 42 | 42 | 62.7 ± 11.3 | 62.1 ± 10.6 | 24/18 | 22/20 | 0.5 g/(kg/d) | PN | Preop-POD 7 |
| Chen et al[42] | 2004 | CC | 24 | 24 | 68.12 ± 4.46 | 66.84 ± 5.52 | 17/7 | 15/9 | 0.4 g /kg/d | PN | Preop. 5 days-POD 7 |
| Cao et al[43] | 2007 | CRC | 20 | 20 | NR | NR | NR | PN | POD1-7 | ||
| Cao et al[44] | 2006 | CRC | 15 | 15 | NR | NR | NR | PN | Preop. 5 days-POD 5 | ||
| Oguz et al[45] | 2007 | CRC | 52 | 57 | 57 ± 17 | 52 ± 12 | 31/21 | 40/17 | 1 g /(kg/d) | PN | Preop.: 6 ± 2, POD: 5 ± 1 |
| Morlion et al[46] | 1998 | CRC | 13 | 15 | 68.2 ± 12.5 | 67.1 ± 10.7 | 6/7 | 6/9 | 0.3 g /(kg/d) | PN | POD1-5 |
| Aosasa et al[47] | 1999 | CRC | 5 | 6 | 54.8 ± 10.7 | 63.8 ± 6.2 | 4/1 | 3/3 | 30 g /d | PN | Preop.: > 5 days |
| Zhang et al[48] | 2012 | CRC | 20 | 20 | 42-74 | NR | 30 g/d | EN | POD1-7 | ||
| Liu et al[49] | 2018 | CC | 40 | 40 | 59.1 ± 7.5 | 61.4 ± 7.0 | 25/15 | 21/19 | 20 g/d | EN | POD1-7 |
| Liu et al[50] | 2017 | CC | 44 | 44 | 59.1 ± 8.5 | 60.4 ± 7.3 | 28/16 | 26/18 | 20 g /d | EN | POD1-7 |
| Li et al[51] | 2016 | RC | 30 | 30 | 50.5 ± 4.9 | 50.1 ± 4.6 | 18/12 | 18/12 | 0.4 g /kg/d | EN | Postop. |
| Li et al[52] | 2019 | CRC | 32 | 32 | 65.5 ± 9.0 | 62.6 ± 9 .6 | 19/13 | 19/13 | 0.5 g/ (kg/d) | EN | POD0.5-7 |
| De et al[53] | 2020 | CC | 52 | 52 | 53.24 ± 11.38 | 53.54 ± 11.57 | 29/23 | 27/25 | 100 mL/d | EN | Preop. 1 day- POD 7 |
| Chen et al[54] | 2022 | CRC | 45 | 45 | 67.9 ± 7.2 | 68.5 ± 7.8 | 25/20 | 27/18 | 30 g /d | EN | POD 1-7 |
| Chen et al[55] | 2014 | CRC | 22 | 22 | 58.7 ± 6.7 | NR | 30 g/d | EN | POD1-10 | ||
| Cai et al[56] | 2021 | RC | 56 | 56 | 68.3 ± 3.6 | 67.2 ± 3.5 | 34/22 | 31/25 | POD2-3: 5 g, POD4-7: 10 g | EN | POD2-7 |
- Citation: Huang Y, Yang XZ, Qin SH, Zhang T, Xie M, Wang JW. Effect of perioperative glutamine-enriched nutritional support on patients with colorectal cancer: A systematic review and meta-analysis. World J Gastrointest Surg 2025; 17(12): 112256
- URL: https://www.wjgnet.com/1948-9366/full/v17/i12/112256.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i12.112256